title: [Inflammation of the jaws during treatment with bisphosphonates].
authors.affiliation: Osteoporosezentrum München am Dom Kaufingerstr., München. reiner.bartl@osteologie-online.de
authors.forename: R
authors.initials: R
authors.lastname: Bartl
mesh_terms: D000284:Administration, Oral; D000368:Aged; D019386:Alendronate / Q000009:adverse effects / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000188:drug therapy*; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D017277:Drug Approval; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D007262:Infusions, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced*; D009894:Opportunistic Infections / Q000139:chemically induced; D010019:Osteomyelitis / Q000139:chemically induced*; D010020:Osteonecrosis / Q000139:chemically induced*; D010024:Osteoporosis / Q000188:drug therapy*; D000077268:Pamidronate; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate; D019386:Alendronate